PCSK9 and prostate carcinoma: Thirdly, using genetic instruments at the PCSK9 locus extracted from a GWAS of LDL-c, liver-derived PCSK9 expression, and circulating PCSK9 protein, this work focuses on the indirect association between PCSK9 inhibition and prostate cancer risk.